FLT3inhibitor quizartinib (AC220)
Author:
Affiliation:
1. Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1602263
Reference88 articles.
1. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
2. Prognostic significance of the Medical Research Council cytogenetic classification compared with the European LeukaemiaNet risk classification system in acute myeloid leukaemia
3. Molecular characterization of acute myeloid leukemia
4. Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
5. Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A systematic review of second-generation FLT3 inhibitors for treatment of patients with relapsed/refractory acute myeloid leukemia;Leukemia Research;2024-06
2. NET-related gene signature for predicting AML prognosis;Scientific Reports;2024-04-20
3. A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-03-26
4. Modulation of Autophagy and Apoptosis in Leukemia;Reference Module in Biomedical Sciences;2024
5. Meta-analysis of the effect of FLT3 inhibitor maintenance therapy on survival and chronic graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for malignant hematologic disease;Cellular and Molecular Biology;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3